These effects, along with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 guidance the principle of focusing on ACKR3 as a novel way to modulate the opioid process, which could open new therapeutic avenues for opioid-related Problems. Notice: Effects may perhaps change https://marcellee406ewp2.jts-blog.com/profile